Real-world Evidence for Label Expansion

 

This video talks about FDA's growing acceptance of the use of real-world data to generate real-world evidence in support of regulatory submissions for pharmaceutical products and medical devices. Dr. Won Chan Lee and Dr. Jennifer Ken-Opurum of Axtria talk about instances where the FDA has approved drugs based on retrospective studies. Watch the video to know more.

 

 

Similar Videos

Jassi Chadha's Spotlight Interview at Reuters Events: Pharma 2022 (Nice, France)
Learn more
Enabling Higher Adoption of Applications Among Field Users
Learn more
Increasing Marketing ROI By 10% With An AI/ML-based Marketing Data Lake
Learn more